2011 Fiscal Year Final Research Report
A novel glaucoma treatment drug research through caspase siRNA.
| Project/Area Number |
21592260
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Saga University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HIRATA Akira 佐賀大学, 医学部, 准教授 (60295144)
ISHIKAWA Shinichiro 佐賀大学, 医学部, 助教 (00404129)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | 遺伝子 / 細胞・組織 / 蛋白質 |
|---|
| Research Abstract |
Intra-vitreous injection of atelocollagen and caspase-3 siRNA complex may protect the retinal ganglion cell damage induced by transient ischemic injury(a glaucoma animal model).
|
Research Products
(4 results)
